InvestorsHub Logo
Followers 0
Posts 107
Boards Moderated 0
Alias Born 03/07/2017

Re: None

Friday, 06/16/2017 11:56:18 AM

Friday, June 16, 2017 11:56:18 AM

Post# of 1317
Great Info!!

On June 6, 2017 it has been resolved by a majority vote from the Board of Directors and Shareholder Minutes of Meeting on June 6, 2017 that the Company will change its Industry Classification to Research and Development in Biotechnology (541714 ) in efforts to prepare for new business ventures, partnerships, business development as a developer and manufacturer of cost-effective dietary supplements and medical foods from organic sources that contain botanical extract blends as an alternative to synthetic drugs and herbal supplements, in efforts to treat pain, cancer, opiates/alcohol withdrawal, epilepsy, PTSD, and other severe illnesses.


Source: http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=12128673